摘要
目的 评价大剂量丙种球蛋白在重症肺炎中的应用价值。方法 对 34例应用丙种球蛋白治疗与 36例未使用丙种球蛋白治疗的重症肺炎病例进行比较 ,包括热退时间、停氧时间、肺部罗音消退时间、痰菌阴转时间及其有效率。结果 丙种球蛋白组在改善症状、消除肺部体征及缩短住院时间和提高治愈率等方面明显优于对照组 (P <0 .0 1)。结论 丙种球蛋白佐治重症肺炎疗效明显 ,未发现明显的副作用。
Objective:To evaluate the value of large-dose of gammaglobulin in the treatment of severe pneumonia in clinical application.Methods:Contrast 34 cases were treated with gammaglobulin and 36cases without gammaglobulin in the defervescene time,oxygen-supply stopping time,pneumonic tale fade-out time,the bacteria inphlegm eliminating time and its efficiency rate.Results:Gammaglobulin group is obviously exceled to the contrastive group in many aspects,such as ameliorating symptom,removing signs,shorting the time in hospital and raising cure rate (P<0.01).Conclusions:The curative effects of gammaglobulin in the treatment of severe pneumonia are obviouly,and no evident side-effects.
出处
《中国现代医学杂志》
CAS
CSCD
2004年第3期132-132,134,共2页
China Journal of Modern Medicine
关键词
丙种球蛋白
重症肺炎
gammaglobulin
severe pneumonia
